# RIGEL PHARMACEUTICALS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:d6cb82f8-d507-4607-98f2-ad7639b9735f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/rigel-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 26 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:44:00.936526+00:00 | | Last reviewed | 2026-10-19T14:44:00.936526+00:00 | ## Identity - Legal name: RIGEL PHARMACEUTICALS INC - Display name: RIGEL PHARMACEUTICALS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-20T03:42:15.588222+00:00 | | Completeness | 0.409 | | Record Quality | 0.837 | | Directors | 16 | | Committees | 1 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Alison L. Hannah: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:5 - David A. Santos: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:7 - Dean L. Schorno: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:8 - Gregg A. Lapointe: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:9 - Jane Wasman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:10 - Kamil Ali-Jackson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:11 - Lisa Rojkjaer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:13 - Mark W. Frohlich: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:14 - Michael P. Miller: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:16 - Raymond J. Furey: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:18 - Walter H. Moos: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-03. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:19 - Alison L. Hannah, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:6 - Kamil Ali-Jackson, J.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:12 - Mark W. Frohlich, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:15 - Raul R. Rodriguez: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:17 - Walter H. Moos, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:20 ## Committees - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Raul R. Rodriguez (member, unknown). committee_id=alpha:committee:rigel-pharmaceuticals-inc:chief-executive-officer-and-director ## Executive leadership - Lisa Rojkjaer: Executive Vice President and Chief Medical Officer. Status: current. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:23 - David A. Santos: Executive Vice President and Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:21 - Dean L. Schorno: Executive Vice President and Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:22 - Lisa Rojkjaer, M.D.: Executive Vice President and Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:24 - Raul R. Rodriguez: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:25 - Raymond J. Furey: Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:26 ## Governance events - DIRECTOR_APPOINTED: Alison L. Hannah seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1j9nkbnyol3vh - DIRECTOR_APPOINTED: David A. Santos seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1qlgiz5mwx80v - DIRECTOR_APPOINTED: Dean L. Schorno seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:87byf41g21dqc - DIRECTOR_APPOINTED: Gregg A. Lapointe seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1tovwa31b289zl - DIRECTOR_APPOINTED: Jane Wasman seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:kx3bqr1h7a7x5 - DIRECTOR_APPOINTED: Kamil Ali-Jackson seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1gamld01yx7hg4 - DIRECTOR_APPOINTED: Lisa Rojkjaer seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:t1tcxao1ovie - DIRECTOR_APPOINTED: Mark W. Frohlich seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1puifsr16u0qrx - DIRECTOR_APPOINTED: Raymond J. Furey seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1b1hlg51pnljz9 - DIRECTOR_APPOINTED: Walter H. Moos seat on RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:10vs8p06i1618 - EXECUTIVE_APPOINTED: Lisa Rojkjaer executive of RIGEL PHARMACEUTICALS INC, effective 2026-04-03. Effective: 2026-04-03. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:ky65g61k4rkm4 - DIRECTOR_APPOINTED: Michael P. Miller seat on RIGEL PHARMACEUTICALS INC, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:15k2sv513vd36x ## Scoped resources - `alpha://company/rigel-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record - `alpha://company/rigel-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/rigel-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/rigel-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=board - `alpha://company/rigel-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/rigel-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/rigel-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/rigel-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/rigel-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/rigel-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/rigel-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/rigel-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/rigel-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/rigel-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/rigel-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/rigel-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/rigel-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/rigel-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/rigel-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/rigel-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=events - `alpha://company/rigel-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/rigel-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/rigel-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Alison L. Hannah: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:5. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Alison L. Hannah, M.D.: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - David A. Santos: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:7. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Dean L. Schorno: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:8. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Gregg A. Lapointe: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:9. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Jane Wasman: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:10. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Kamil Ali-Jackson: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:11. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Kamil Ali-Jackson, J.D.: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - Lisa Rojkjaer: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:13. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Mark W. Frohlich: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:14. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Mark W. Frohlich, M.D.: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - Michael P. Miller: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:16. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Raul R. Rodriguez: President, Chief Executive Officer and Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - Raymond J. Furey: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:18. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Walter H. Moos: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:19. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c. - Walter H. Moos, Ph.D.: Director. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - David A. Santos: Executive Vice President and Chief Commercial Officer. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - Dean L. Schorno: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - Lisa Rojkjaer: Executive Vice President and Chief Medical Officer. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:23. Valid from: 2026-04-03. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:665a209ae677d987255b2ef2c66e22b628f07b08ef82c0bd06459048c8d6da85. - Lisa Rojkjaer, M.D.: Executive Vice President and Chief Medical Officer. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - Raul R. Rodriguez: President and Chief Executive Officer. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. - Raymond J. Furey: Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - RIGEL PHARMACEUTICALS INC. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8f5dfaf45f3a52d2e1c2cf451a4b76f62df1757f821e72d8f0cdd0530453ff49. ## Entity Status - Public listing published. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8f5dfaf45f3a52d2e1c2cf451a4b76f62df1757f821e72d8f0cdd0530453ff49. ## Published Fact - US. Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8f5dfaf45f3a52d2e1c2cf451a4b76f62df1757f821e72d8f0cdd0530453ff49. ## Security Listing - RIGL (NASDAQ). Claim: alpha:claim:company:d6cb82f8-d507-4607-98f2-ad7639b9735f:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8f5dfaf45f3a52d2e1c2cf451a4b76f62df1757f821e72d8f0cdd0530453ff49. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:8f5dfaf45f3a52d2e1c2cf451a4b76f62df1757f821e72d8f0cdd0530453ff49: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc). - alpha:projection-evidence:document:81f2a8d522a50fc35ea112f6829867a14a9ca106e56b03cb5f1b247a2abf132c: [DEF 14A rigl-20260403.htm](https://www.sec.gov/Archives/edgar/data/1034842/000103484226000023/rigl-20260403.htm). - alpha:projection-evidence:document:57a0a1df22d4baf362096a9f7d671c6b8e84c2e5146035135c59182521c6f038: [SEC DEF 14A 0001034842-26-000023](https://www.sec.gov/Archives/edgar/data/1034842/000103484226000023/rigl-20260403.htm). - alpha:projection-evidence:document:665a209ae677d987255b2ef2c66e22b628f07b08ef82c0bd06459048c8d6da85: [RIGL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1034842/000103484226000023/rigl-20260403.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/rigel-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/rigel-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/rigel-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/rigel-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-20T03:42:15.388424+00:00; recorded 2026-10-20T03:42:15.388424+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.